Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,474.70
    -1,118.00 (-2.17%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

League suspends marijuana tests for 2020-21 season, cites pandemic challenges

The NBA logo is displayed as people pass by the NBA Store in New York

(Reuters) - The National Basketball Association (NBA) and its NBPA players' association have agreed to suspend random testing for marijuana during the 2020-21 season, a league spokesman said on Friday.

Players have already arrived in their home cities for the 72-game season, which starts on Dec. 22, two months after the NBA concluded last season inside a controlled quarantine "bubble" at Walt Disney World due to the COVID-19 pandemic.

"Due to the unusual circumstances in conjunction with the pandemic, we have agreed with the NBPA to suspend random testing for marijuana for the 2020-21 season and focus our random testing program on performance-enhancing products and drugs of abuse," league spokesman Mike Bass said.

A total of 48 players out of 546 tested positive for COVID-19 as part of the NBA's "initial return-to-market testing phase," the league said on Wednesday.

(Reporting by Amy Tennery; Editing by Ken Ferris)